Last reviewed: July 8, 2026
Last updated: July 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injection belongs to a class of medications called GLP-1 receptor agonists, which mimic a natural hormone that regulates appetite and blood sugar. Originally approved by the FDA in 2017 for type 2 diabetes management, semaglutide has since become widely used for weight loss because it consistently produces significant reductions in body weight when combined with lifestyle changes. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies to all 50 states, offering personalized dosing pathways without membership fees or insurance requirements.
How Semaglutide Injection Works in Your Body
Semaglutide functions by activating GLP-1 receptors, which are found throughout your brain, gut, and pancreas. When these receptors are stimulated, they send signals that reduce hunger, increase feelings of fullness, and slow the rate at which food moves through your stomach. This three-part mechanism leads to naturally lower calorie intake without requiring extreme willpower or restrictive eating patterns.
The medication also improves how your pancreas releases insulin in response to meals, helping regulate blood sugar levels more effectively. Clinical trials show that people using semaglutide typically lose 10-15% of their starting body weight over 68 weeks, with some achieving even greater results when paired with structured nutrition and exercise programs. These outcomes have made semaglutide one of the most researched and prescribed options for metabolic weight management globally.
Primary Medical Uses of Semaglutide Injections
Type 2 diabetes management remains one of the original and most established uses of semaglutide. The medication helps people with diabetes control fasting and post-meal blood sugar levels, reducing their risk of serious complications like heart disease, kidney damage, and vision loss. Many diabetes patients report improved energy levels and reduced diabetic symptoms after starting semaglutide therapy.
Weight management and obesity treatment now represent the largest growing use of semaglutide in clinical practice. People struggling with excess weight who have tried conventional dieting methods without lasting success often see transformative results with semaglutide injections. The medication is particularly valuable for individuals with weight-related conditions such as high blood pressure, sleep apnea, or joint problems, where even modest weight loss produces measurable health improvements.
Emerging research suggests semaglutide may offer cardiovascular benefits beyond weight loss alone. Studies indicate that GLP-1 receptor agonists like semaglutide reduce the risk of major heart attacks and strokes in people with type 2 diabetes or existing heart disease, independent of how much weight they lose. This broader protective effect makes semaglutide relevant for patients focused on long-term heart health as well as metabolic goals.
Semaglutide Dosing and Administration for Different Goals
Semaglutide injections are administered once weekly as a subcutaneous injection, typically in the abdomen, thigh, or upper arm. Patients self-administer the injection after receiving proper training from their healthcare provider or PlexusDx care team. The starting dose is usually low, and most protocols involve gradual increases every 4 weeks to allow your body to adapt and minimize side effects while reaching therapeutic levels.
PlexusDx provides personalized dose escalation based on your individual response and tolerance, with your dose potentially increasing over time while your monthly price remains flat. Your provider monitors your progress through regular check-ins and may adjust the schedule based on your weight loss trajectory, hunger reduction, and how well you tolerate the medication. This flexible approach means you pay the same each month regardless of whether you're starting or maintaining at a higher therapeutic dose.
Why Genetic Testing Helps Optimize Semaglutide Response
Not everyone responds to semaglutide with the same degree of weight loss or appetite suppression, partly because genetic variations affect how your body processes GLP-1 signals. The PlexusDx Precision Peptide Genetic Test examines key variants like GLP1R rs6923761 and GIPR rs1800437 that influence your natural sensitivity to these pathways. Understanding your genetic profile helps your PlexusDx provider predict whether you'll respond best to semaglutide alone or if a dual-compound option like GLP-Squared might deliver better results for your unique metabolism.
Your genetic insights also inform decisions about starting doses and escalation timelines. Patients with certain peptide-pathway variants may benefit from slower, more conservative dose increases to minimize nausea, while others with different genetic backgrounds might reach therapeutic doses more quickly. This precision approach reduces trial-and-error and helps you achieve meaningful results faster by matching the medication strategy to your biological reality rather than using a one-size-fits-all protocol.
Comparing Semaglutide to Other Weight Loss Medication Options
Tirzepatide, another GLP-1 receptor agonist available through PlexusDx, works similarly to semaglutide but also activates GIP receptors, a second hormone pathway involved in appetite and metabolism. Some patients achieve faster or greater weight loss with tirzepatide, though both medications require consistent use and lifestyle support to maintain results. Your PlexusDx provider can help determine which option aligns best with your health history, genetic profile, and treatment goals.
Oral forms of both semaglutide and tirzepatide are available for patients who prefer taking tablets instead of injections, though these typically require higher doses and may be less consistent in absorption. PlexusDx also offers the Microdose GLP-1 Protocol for those seeking entry-level access, and the GLP-Squared dual-compound injection combines semaglutide and tirzepatide for patients who need multi-pathway activation. The choice between these options depends on your individual response, lifestyle preferences, and whether genetic testing reveals that your peptide pathways respond better to single or dual approaches.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is semaglutide injection primarily used for today?
Semaglutide injection is FDA-approved for type 2 diabetes management and has become widely used off-label for weight loss because it reduces hunger and increases fullness. Most people using semaglutide injections today are seeking weight management and metabolic health benefits, often with the guidance of specialized providers like those at PlexusDx.
How much weight can you typically lose with semaglutide injections?
Clinical trials show average weight loss of 10-15% of starting body weight over 68 weeks, with some patients achieving 20% or greater losses. Results vary based on your genetics, adherence to healthy eating patterns, physical activity, and how well your body responds to GLP-1 stimulation, which is why genetic testing through PlexusDx can help predict your likely outcome.
Is PlexusDx semaglutide injection available everywhere, and how much does it cost?
Yes, PlexusDx serves all 50 states with no insurance required and no membership fees. Compounded semaglutide injection starts at $149/month, and your dose may increase over time while your monthly price remains flat—you won't pay more as your dose adjusts.
What are the most common side effects of semaglutide injections?
Nausea, vomiting, and constipation are the most frequently reported side effects, especially when starting or increasing doses. Most side effects diminish within days to weeks as your body adapts, and they're usually milder with slower dose escalation. Serious side effects are rare, but you should discuss any concerning symptoms with your PlexusDx provider immediately.
Can genetic testing predict how well semaglutide will work for me?
The PlexusDx Precision Peptide Genetic Test examines variants in GLP1R, GIPR, and other pathways that influence your natural appetite regulation and medication response. While genetics are one factor among many, this test helps your provider predict whether you'll respond optimally to semaglutide alone or benefit more from tirzepatide or dual-compound therapy, increasing your chances of meaningful weight loss.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Is the Lowest Dose of Wegovy and How Does Its Dosage Schedule Work?
When You Stop Losing Weight on Ozempic: Understanding the Plateau and What to Do Next